Literature DB >> 9621092

CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: lack of association with mutations other than CCR5-Delta32.

O J Cohen1, S Paolucci, S M Bende, M Daucher, H Moriuchi, M Moriuchi, C Cicala, R T Davey, B Baird, A S Fauci.   

Abstract

Polymorphisms in the coding sequences of CCR5 and CXCR4 were studied in a group of human immunodeficiency virus (HIV)-infected long-term nonprogressors. Two different point mutations were found in the CXCR4 coding sequence. One of these CXCR4 mutations was silent, and each was unique to two nonprogressors. The well-described 32-bp deletion within the CCR5 coding sequence (CCR5-Delta32) was found in 4 of 13 nonprogressors, and 12 different point mutations were found scattered over the CCR5 coding sequence from 8 nonprogressors. Most of the mutations created either silent or conservative changes in the predicted amino acid sequence: only one of these mutations was found in more than a single nonprogressor. All nonsilent mutations were tested in an HIV envelope-dependent fusion assay, and all functioned comparably to wild-type controls. Polymorphisms in the CXCR4 and CCR5 coding sequences other than CCR5-Delta32 do not appear to play a dominant mechanistic role in nonprogression among HIV-infected individuals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621092      PMCID: PMC110440     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

Authors:  M W Smith; M Dean; M Carrington; C Winkler; G A Huttley; D A Lomb; J J Goedert; T R O'Brien; L P Jacobson; R Kaslow; S Buchbinder; E Vittinghoff; D Vlahov; K Hoots; M W Hilgartner; S J O'Brien
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

2.  The extent of genetic variation in the CCR5 gene.

Authors:  M A Ansari-Lari; X M Liu; M L Metzker; A R Rut; R A Gibbs
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

3.  HIV-1 infection in an individual homozygous for CCR5 delta 32. Seroco Study Group.

Authors:  I Theodorou; L Meyer; M Magierowska; C Katlama; C Rouzioux
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

4.  Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.

Authors:  O J Cohen; M Vaccarezza; G K Lam; B F Baird; K Wildt; P M Murphy; P A Zimmerman; T B Nutman; C H Fox; S Hoover; J Adelsberger; M Baseler; J Arthos; R T Davey; R L Dewar; J Metcalf; D J Schwartzentruber; J M Orenstein; S Buchbinder; A J Saah; R Detels; J Phair; C Rinaldo; J B Margolick; G Pantaleo; A S Fauci
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

5.  Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1.

Authors:  H Moriuchi; M Moriuchi; J Arthos; J Hoxie; A S Fauci
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.

Authors:  J Eugen-Olsen; A K Iversen; P Garred; U Koppelhus; C Pedersen; T L Benfield; A M Sorensen; T Katzenstein; E Dickmeiss; J Gerstoft; P Skinhøj; A Svejgaard; J O Nielsen; B Hofmann
Journal:  AIDS       Date:  1997-03       Impact factor: 4.177

7.  The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Authors:  N L Michael; G Chang; L G Louie; J R Mascola; D Dondero; D L Birx; H W Sheppard
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

Review 8.  Host factors in the pathogenesis of HIV disease.

Authors:  O J Cohen; A Kinter; A S Fauci
Journal:  Immunol Rev       Date:  1997-10       Impact factor: 12.988

9.  Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)

Authors:  C Winkler; W Modi; M W Smith; G W Nelson; X Wu; M Carrington; M Dean; T Honjo; K Tashiro; D Yabe; S Buchbinder; E Vittinghoff; J J Goedert; T R O'Brien; L P Jacobson; R Detels; S Donfield; A Willoughby; E Gomperts; D Vlahov; J Phair; S J O'Brien
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

10.  CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.

Authors:  L Wu; W A Paxton; N Kassam; N Ruffing; J B Rottman; N Sullivan; H Choe; J Sodroski; W Newman; R A Koup; C R Mackay
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

View more
  16 in total

Review 1.  Host genetic factors in susceptibility to HIV-1 infection and progression to AIDS.

Authors:  Koushik Chatterjee
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

2.  The Distribution of CCR2-64I, SDF1-3'A and MCP1-2518 G/A Genes Polymorphism in a Specific High Risk Group from the Northeastern States West Bengal, and Gorkha Population in India.

Authors:  Partha Roy; Sekhar Chakrabarti
Journal:  Indian J Virol       Date:  2012-09-12

Review 3.  Success and failure of the cellular immune response against HIV-1.

Authors:  Stephen A Migueles; Mark Connors
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

Review 4.  Chemokines, their receptors and human disease: the good, the bad and the itchy.

Authors:  Vanessa L Bryant; Charlotte A Slade
Journal:  Immunol Cell Biol       Date:  2015-04       Impact factor: 5.126

5.  Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population.

Authors:  Desiree C Petersen; Richard H Glashoff; Sadeep Shrestha; Julie Bergeron; Annette Laten; Bert Gold; Estrelita Janse van Rensburg; Michael Dean; Vanessa M Hayes
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-15       Impact factor: 3.731

6.  Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution.

Authors:  S E Kuhmann; N Madani; O M Diop; E J Platt; J Morvan; M C Müller-Trutwin; F Barré-Sinoussi; D Kabat
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  C868T single nucleotide polymorphism and HIV type 1 disease progression among postpartum women in Kenya.

Authors:  Robert Y Choi; Keith R Fowke; Jennifer Juno; Barbara Lohman-Payne; Julius O Oyugi; Elizabeth R Brown; Rose Bosire; Grace John-Stewart; Carey Farquhar
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-27       Impact factor: 2.205

8.  Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes.

Authors:  Toshiyuki Miura; Mark A Brockman; Chanson J Brumme; Zabrina L Brumme; Jonathan M Carlson; Florencia Pereyra; Alicja Trocha; Marylyn M Addo; Brian L Block; Alissa C Rothchild; Brett M Baker; Theresa Flynn; Arne Schneidewind; Bin Li; Yaoyu E Wang; David Heckerman; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  Polymorphism of human and primate RANTES, CX3CR1, CCR2 and CXCR4 genes with regard to HIV/SIV infection.

Authors:  Bénédicte Puissant; Michel Abbal; Antoine Blancher
Journal:  Immunogenetics       Date:  2003-07-23       Impact factor: 2.846

10.  The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.

Authors:  Stephen A Migueles; Alisha C Laborico; Hiromi Imamichi; W Lesley Shupert; Cassandra Royce; Mary McLaughlin; Linda Ehler; Julia Metcalf; Shuying Liu; Claire W Hallahan; Mark Connors
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.